Company Overview of Nuron Biotech Inc.
Nuron Biotech Inc. develops specialty biologics and vaccines. Its product pipeline comprises central nervous system products, such as NU100, a recombinant human interferon beta-1b for the treatment of relapsing remitting multiple sclerosis; wound healing products, including NU200, a recombinant human epidermal growth factor product for healing diabetic foot ulcers and burns; and HibTITER, a conjugate vaccine. The company was founded in 2010 and is based in Exton, Pennsylvania.
1 East Uwchlan Avenue
Exton, PA 19341
Founded in 2010
Key Executives for Nuron Biotech Inc.
Nuron Biotech Inc. Key Developments
Similar Private Companies By Industry
|Semafore Pharmaceuticals, Inc.||United States|
|REN Pharmaceuticals, Inc.||United States|
|Kelatron Corporation||United States|
|Sova Pharmaceuticals, Inc.||United States|
|Ceva Animal Health LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Nuron Biotech Inc., please visit www.nuronbiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.